Quarterly ResultMay 7, 2026, 04:22 PM
Astrana Health Q1 Revenue +56% to $965.1M; Adj. EBITDA +82%
AI Summary
Astrana Health reported strong first-quarter 2026 financial results, with total revenue increasing 56% year-over-year to $965.1 million and adjusted EBITDA rising 82% to $66.3 million. The company also saw a significant 372% increase in free cash flow to $64.1 million and a 116% rise in net income. Astrana Health reaffirmed its full-year 2026 guidance for total revenue, adjusted EBITDA, and free cash flow, highlighting disciplined growth and strong medical cost performance.
Key Highlights
- Total revenue increased 56% year-over-year to $965.1 million for Q1 2026.
- Adjusted EBITDA grew 82% year-over-year to $66.3 million.
- Free cash flow surged 372% year-over-year to $64.1 million.
- Net income attributable to Astrana Health rose 116% to $14.4 million.
- Care Partners revenue increased 51% to $909.7 million.
- Approximately 80% of Care Partners capitation revenue is now from full-risk arrangements.
- Reaffirmed full-year 2026 guidance: revenue $3.8B-$4.1B, Adj. EBITDA $250M-$280M.
- Net leverage declined to approximately 2.3x on a pro forma trailing twelve-month basis.